These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9749578)

  • 1. Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress?
    Münch G; Gerlach M; Sian J; Wong A; Riederer P
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S85-8. PubMed ID: 9749578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?
    Münch G; Lüth HJ; Wong A; Arendt T; Hirsch E; Ravid R; Riederer P
    J Chem Neuroanat; 2000 Dec; 20(3-4):253-7. PubMed ID: 11207423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
    Dalfó E; Portero-Otín M; Ayala V; Martínez A; Pamplona R; Ferrer I
    J Neuropathol Exp Neurol; 2005 Sep; 64(9):816-30. PubMed ID: 16141792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
    Castellani R; Smith MA; Richey PL; Perry G
    Brain Res; 1996 Oct; 737(1-2):195-200. PubMed ID: 8930366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding cell death in Parkinson's disease.
    Jenner P; Olanow CW
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S72-84. PubMed ID: 9749577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins.
    Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT
    Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?
    Hirsch EC; Hunot S; Damier P; Faucheux B
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S115-20. PubMed ID: 9749582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and Parkinson's disease.
    Owen AD; Schapira AH; Jenner P; Marsden CD
    Ann N Y Acad Sci; 1996 Jun; 786():217-23. PubMed ID: 8687021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione, iron and Parkinson's disease.
    Bharath S; Hsu M; Kaur D; Rajagopalan S; Andersen JK
    Biochem Pharmacol; 2002 Sep; 64(5-6):1037-48. PubMed ID: 12213603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease.
    Sharma A; Weber D; Raupbach J; Dakal TC; Fließbach K; Ramirez A; Grune T; Wüllner U
    Redox Biol; 2020 Jul; 34():101546. PubMed ID: 32460130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of inducible type nitric oxide synthase against intracellular oxidative stress caused by advanced glycation end-products in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
    Mizutani K; Ikeda K; Ito T; Tamaki K; Nara Y; Yamori Y
    J Hypertens; 2000 Aug; 18(8):1071-9. PubMed ID: 10953999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Jenner P; Dexter DT; Sian J; Schapira AH; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S82-7. PubMed ID: 1510385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.
    Ren X; Ren L; Wei Q; Shao H; Chen L; Liu N
    Cardiovasc Diabetol; 2017 Apr; 16(1):52. PubMed ID: 28427390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
    J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease.
    Foley P; Riederer P
    J Neurol; 2000 Apr; 247 Suppl 2():II82-94. PubMed ID: 10991671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease--a target for neuroprotective treatment strategies?
    Münch G; Deuther-Conrad W; Gasic-Milenkovic J
    J Neural Transm Suppl; 2002; (62):303-7. PubMed ID: 12456073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans.
    Castellani RJ; Perry G; Siedlak SL; Nunomura A; Shimohama S; Zhang J; Montine T; Sayre LM; Smith MA
    Neurosci Lett; 2002 Feb; 319(1):25-8. PubMed ID: 11814645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and the pathogenesis of Parkinson's disease.
    Jenner P; Olanow CW
    Neurology; 1996 Dec; 47(6 Suppl 3):S161-70. PubMed ID: 8959985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.